Interestingly, these gene fusions were mutually exclusive with JAK1/STAT3 mutations, suggesting convergent pathogenetic mechanisms and therapeutic targets for ALK negative ALCL (Figure 1). Here, ALK is linked to anaplastic large cell lymphoma.